[go: up one dir, main page]

FI925661A0 - Injicerbar farmaceutisk komposition - Google Patents

Injicerbar farmaceutisk komposition

Info

Publication number
FI925661A0
FI925661A0 FI925661A FI925661A FI925661A0 FI 925661 A0 FI925661 A0 FI 925661A0 FI 925661 A FI925661 A FI 925661A FI 925661 A FI925661 A FI 925661A FI 925661 A0 FI925661 A0 FI 925661A0
Authority
FI
Finland
Prior art keywords
microspheres
formulations
contain
dia
microns
Prior art date
Application number
FI925661A
Other languages
English (en)
Other versions
FI107698B (fi
FI925661L (fi
Inventor
Flores Josue Garza
Soto Laura P Laiseca
Pichardo Jose Guillen
Uribe Juan Angeles
Original Assignee
Aplicaciones Farmaceuticas
Tripet Marc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmaceuticas, Tripet Marc filed Critical Aplicaciones Farmaceuticas
Publication of FI925661L publication Critical patent/FI925661L/fi
Publication of FI925661A0 publication Critical patent/FI925661A0/fi
Application granted granted Critical
Publication of FI107698B publication Critical patent/FI107698B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI925661A 1990-06-14 1992-12-11 Kiinteitä, ei-huokoisia mikropallosia FI107698B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.
FR9007416 1990-06-14
PCT/EP1991/001096 WO1991019484A1 (fr) 1990-06-14 1991-06-12 Composition pharmaceutique injectable
EP9101096 1991-06-12

Publications (3)

Publication Number Publication Date
FI925661L FI925661L (fi) 1992-12-11
FI925661A0 true FI925661A0 (fi) 1992-12-11
FI107698B FI107698B (fi) 2001-09-28

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925661A FI107698B (fi) 1990-06-14 1992-12-11 Kiinteitä, ei-huokoisia mikropallosia

Country Status (30)

Country Link
US (3) US5360616A (fi)
EP (1) EP0533739B1 (fi)
JP (1) JP2675675B2 (fi)
KR (1) KR0157439B1 (fi)
CN (1) CN1057442C (fi)
AT (1) ATE109658T1 (fi)
AU (1) AU661275B2 (fi)
BG (1) BG61179B1 (fi)
BR (1) BR9106545A (fi)
CA (1) CA2085344C (fi)
CZ (1) CZ286793B6 (fi)
DE (1) DE69103419T2 (fi)
DK (1) DK0533739T3 (fi)
ES (1) ES2059142T3 (fi)
FI (1) FI107698B (fi)
FR (1) FR2663223B1 (fi)
HU (1) HUT68709A (fi)
IE (1) IE62679B1 (fi)
IL (1) IL98459A (fi)
NO (1) NO302998B1 (fi)
NZ (1) NZ238542A (fi)
PL (1) PL167234B1 (fi)
PT (1) PT97975B (fi)
RU (1) RU2104692C1 (fi)
SK (1) SK280564B6 (fi)
TN (1) TNSN91048A1 (fi)
UA (1) UA27043C2 (fi)
UY (1) UY23240A1 (fi)
WO (1) WO1991019484A1 (fi)
ZA (1) ZA914550B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
ATE265846T1 (de) * 1998-02-25 2004-05-15 Abbott Lab Butorphanol enthaltende formulierungen mit verzögerter freisetzung
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
JP2003526629A (ja) * 1999-08-20 2003-09-09 ノートン ヘルスケアー リミテッド 経肺または経鼻投与のための粉末の製造法
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
AU2004246870B2 (en) * 2003-06-13 2009-07-23 Skendi Finance Ltd Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
ES2535430T3 (es) 2003-09-03 2015-05-11 Miscon Trading S.A. Métodos para el tratamiento de la endometriosis
EP1684782B1 (en) 2003-10-03 2015-09-30 Thorn BioScience, LLC Process for the synchronization of ovulation for timed breeding without heat detection
PL1675573T4 (pl) * 2003-10-23 2016-04-29 Otsuka Pharma Co Ltd Sterylny preparat do wstrzykiwań arypiprazolu o kontrolowanym uwalnianiu i sposób
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
EP2078052B1 (en) 2006-10-31 2010-07-28 Surmodics Pharmaceuticals, Inc. Spheronized polymer particles
JP4879349B2 (ja) 2007-07-31 2012-02-22 大塚製薬株式会社 アリピプラゾール懸濁液及び凍結乾燥製剤の製造方法
JP2011516606A (ja) * 2008-04-14 2011-05-26 ポジ ビジョナリー ソリューションズ エルエルピー 様々な治療指標に必要な血漿プロゲステロン濃度を得るための方法および医薬組成物
CN104906556A (zh) 2009-04-23 2015-09-16 Jbs联合动物健康二有限公司 用于同步授精时间的方法和组合物
UY33103A (es) * 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
WO2014085674A1 (en) 2012-11-28 2014-06-05 Jbs United Animal Health Ii Llc Method for synchronizing time of insemination in gilts
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
JP2019506443A (ja) * 2016-02-24 2019-03-07 イースタン バージニア メディカル スクール 改良された持効性注射用デポ型ブタン酸レボノルゲストレル懸濁製剤
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用
CN116036022A (zh) * 2021-12-24 2023-05-02 中国人民解放军军事科学院军事医学研究院 一种新型的含载体材料的药物微球制备及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (fi) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (fi) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
ATE74009T1 (de) * 1986-08-11 1992-04-15 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
ATE109941T1 (de) * 1987-04-06 1994-09-15 Endocon Inc Durch schnellschmelzen hergestellte medizinische implantate.
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
ATE99546T1 (de) * 1989-05-01 1994-01-15 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen.

Also Published As

Publication number Publication date
CA2085344A1 (en) 1991-12-15
IL98459A (en) 1996-09-12
CZ286793B6 (cs) 2000-07-12
DK0533739T3 (da) 1995-01-09
BG97166A (bg) 1993-12-24
JP2675675B2 (ja) 1997-11-12
US5360616A (en) 1994-11-01
ES2059142T3 (es) 1994-11-01
SK280564B6 (sk) 2000-03-13
BR9106545A (pt) 1993-06-01
US5633014A (en) 1997-05-27
CA2085344C (en) 1998-06-30
EP0533739A1 (fr) 1993-03-31
NO924792L (no) 1993-02-03
TNSN91048A1 (fr) 1992-10-25
HU9203958D0 (en) 1993-03-29
NZ238542A (en) 1993-09-27
FR2663223B1 (fr) 1994-12-02
HUT68709A (en) 1995-07-28
DE69103419T2 (de) 1995-03-30
KR0157439B1 (ko) 1998-11-16
FR2663223A1 (fr) 1991-12-20
WO1991019484A1 (fr) 1991-12-26
AU661275B2 (en) 1995-07-20
PT97975A (pt) 1992-04-30
IL98459A0 (en) 1992-07-15
IE62679B1 (en) 1995-02-22
CS181691A3 (en) 1992-06-17
CN1057442C (zh) 2000-10-18
FI107698B (fi) 2001-09-28
FI925661L (fi) 1992-12-11
UY23240A1 (es) 1991-07-12
CN1057961A (zh) 1992-01-22
NO924792D0 (no) 1992-12-11
US5512303A (en) 1996-04-30
IE912017A1 (en) 1991-12-18
PL290677A1 (en) 1992-11-30
PL167234B1 (pl) 1995-08-31
ATE109658T1 (de) 1994-08-15
AU8084791A (en) 1992-01-07
UA27043C2 (uk) 2000-02-28
ZA914550B (en) 1992-03-25
PT97975B (pt) 1998-11-30
NO302998B1 (no) 1998-05-18
DE69103419D1 (de) 1994-09-15
EP0533739B1 (fr) 1994-08-10
RU2104692C1 (ru) 1998-02-20
BG61179B1 (bg) 1997-02-28
JPH05507694A (ja) 1993-11-04

Similar Documents

Publication Publication Date Title
FI925661A0 (fi) Injicerbar farmaceutisk komposition
IL170181A (en) (4r) and (4s)-diastereoisomers of (2s)-2-[oxy-4-propylpyrrolidinyl]butanamide, pharmaceutical compositions comprising them and their use for preparing medicaments
CA2275479A1 (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
ATE77946T1 (de) Injizierbares langwirkendes mikroteilchenpr|parat zur verabreichung entzuendungshemmender mittel.
HRP20040033B1 (en) Dry powder inhalation system for transpulmonary administration
DE69631290D1 (de) Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren
EP0131485A3 (en) Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion : expanded range
GEP20032868B (en) Triazolo-Pyridazine Derivatives as Ligands for Gaba Receptors, Methods for Their Production, Pharmaceutical Compositions Containing the Same for Treatment and/or Prevention of disorders of Central Nervous System
BR9808331A (pt) Aparelho para quebra de partìculas e separação das partìculas de produto e partìculas residuais e composição de partìculas
DZ2300A1 (fr) Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr) Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
HRP20080410A2 (en) Crystalline composition containing escitalopram
BR9809279A (pt) Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato
CO4900080A1 (es) Microesferas farmaceuticas de acido valproico para administracion oral
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
HUP0004405A2 (hu) Polietilénglikol mátrixszemcsék zsíros, olajos vagy ragacsos gyógyszerhatóanyagokhoz
IL113178A0 (en) 8 alpha-3-hydroxyestra-1,3,5(11) tetraen-17-one (delta9(11)-dehydro-8 isoestrone its preparation andpharmaceutical composition containing it and its use
DK0482183T3 (da) Histamin-H3-receptoragonistforbindelser til terapeutisk anvendelse, farmaceutiske sammensætninger virkende som agonister for nævnte receptor og fremstillingsmetode
IL94347A0 (en) Arylsulphonamides,their preparation and pharmaceutical compositions containing them
AU1381401A (en) Method and device for producing powders that consist of substantially spherical particles
FR2705570B1 (fr) Nouvelle formulation d'aérosol médicamentaux à base de fusafungine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent.
MX9307009A (es) Derivados de 5-[(imidaol{4,5-b}piridin-3-il]metil/benzofurano, procesopara su preparacion y composiciones farmaceuticas que los contienen.
BE901254A (fr) Formulations pharmaceutiques et veterinaires.